Literature DB >> 10234494

Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers.

N G Levein1, S E Thörn, M Wattwil.   

Abstract

Dopamine decreases gastric tone and may therefore influence gastrointestinal motility. The aim of this investigation was to study the effects of a continuous infusion of dopamine on gastric emptying and orocaecal transit time. Nine healthy male volunteers were studied on two occasions in a randomized order. All volunteers received on separate days a continuous infusion of dopamine 5 micrograms kg-1 min-1 on one occasion and normal saline on the other occasion. Gastric emptying was measured by the paracetamol absorption test and orocaecal transit time by the hydrogen breath test. During the dopamine infusion the area under the paracetamol concentration curve was significantly smaller than during control conditions (P = 0.02). Orocaecal transit time was prolonged during the dopamine infusion (P = 0.02). Dopamine delays gastric emptying and prolongs orocaecal transit time.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234494     DOI: 10.1046/j.1365-2346.1999.00471.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  13 in total

Review 1.  Constipation in neurological diseases.

Authors:  K Winge; D Rasmussen; L M Werdelin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Antro-pyloro-duodenal motor responses to gastric and duodenal nutrient in critically ill patients.

Authors:  M Chapman; R Fraser; R Vozzo; L Bryant; W Tam; N Nguyen; B Zacharakis; R Butler; G Davidson; M Horowitz
Journal:  Gut       Date:  2005-05-29       Impact factor: 23.059

3.  Chronic constipation: improved understanding offers a new therapeutic approach.

Authors:  Gareth J Sanger
Journal:  J Physiol       Date:  2016-08-01       Impact factor: 5.182

4.  Does domperidone, a D2-antagonist alter gastric emptying rates and appetite sensations in healthy adults with high-fat meal? A block-randomised, single-blind placebo-controlled study.

Authors:  O Markey; A Shafat
Journal:  Ir J Med Sci       Date:  2011-11-29       Impact factor: 1.568

Review 5.  Bladder and bowel dysfunction in Parkinson's disease.

Authors:  R Sakakibara; T Uchiyama; T Yamanishi; K Shirai; T Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-03-10       Impact factor: 3.575

Review 6.  Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Authors:  Vinod Metta; Valentina Leta; Kandadai Rukmini Mrudula; L K Prashanth; Vinay Goyal; Rupam Borgohain; Guy Chung-Faye; K Ray Chaudhuri
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

7.  Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying.

Authors:  Kayode Ogungbenro; Henry Pertinez; Leon Aarons
Journal:  AAPS J       Date:  2014-11-21       Impact factor: 4.009

8.  Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model".

Authors:  Marty Hinz; Alvin Stein; Thomas Uncini
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-20

9.  The Parkinson's disease death rate: carbidopa and vitamin B6.

Authors:  Marty Hinz; Alvin Stein; Ted Cole
Journal:  Clin Pharmacol       Date:  2014-10-21

10.  Is Hydrogen Breath Test with Lactulose Feasible for Measuring Gastrocecal Transit in Critically Ill Children? Pilot Study about Modification of the Technique.

Authors:  J López; C Sánchez; S N Fernández; R González; M J Solana; J Urbano; M Tolín; J López-Herce
Journal:  Biomed Res Int       Date:  2017-01-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.